TYRP1 and neoplasm: We evaluated this with both hTRP2 and VP22-Opt-TRP1 and found that indeed, radiation and lymphocyte infusion improved tumor rejection at day 12 after final immunization (Figure 4B), though by day 19 this enhancement was no longer evident.